Ligand validation:6CRD

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 6CRD designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6CRD_NAG_A_516	75%	41%	0.107	0.94	0.73	1.53	-	3	0	0	100%	0.9333
6CRD_NAG_C_514	68%	17%	0.125	0.936	0.76	2.76	-	5	1	0	100%	0.9333
6CRD_NAG_B_512	58%	20%	0.15	0.929	1.04	2.28	1	4	0	0	100%	0.9333
6CRD_NAG_E_514	54%	38%	0.146	0.911	0.74	1.68	1	2	0	0	100%	0.9333
6CRD_NAG_G_514	51%	30%	0.133	0.887	0.91	1.84	1	2	1	0	100%	0.9333
6CRD_NAG_B_513	49%	39%	0.152	0.898	0.71	1.66	-	3	1	0	100%	0.9333
6CRD_NAG_H_514	44%	34%	0.162	0.888	0.86	1.73	1	3	0	0	100%	0.9333
6CRD_NAG_F_514	36%	38%	0.163	0.856	0.91	1.5	1	4	0	0	100%	0.9333
1NCC_NAG_N_475	86%	22%	0.104	0.974	1.45	1.78	2	5	1	0	100%	0.9333
2C4L_NAG_A_1472	85%	44%	0.088	0.964	0.46	1.69	-	5	5	0	93%	0.9333
7NN9_NAG_A_476	69%	29%	0.085	0.898	1.07	1.76	-	3	0	0	100%	0.9333
1NCA_NAG_N_475	61%	39%	0.111	0.898	0.97	1.42	-	2	0	0	100%	0.9333
5NN9_NAG_A_477	59%	42%	0.15	0.933	0.86	1.36	-	3	0	0	100%	0.9333
3PPS_NAG_B_760	100%	44%	0.028	0.993	0.57	1.57	-	3	0	0	100%	0.9333
4AKM_NAG_A_1379	100%	67%	0.029	0.994	0.54	0.73	-	-	0	0	100%	0.9333
3CQL_NAG_B_244	100%	68%	0.029	0.987	0.42	0.8	-	-	0	0	100%	1
3RIK_NAG_D_509	100%	8%	0.035	0.991	2.03	2.54	4	7	2	0	100%	0.9333
5VEM_NAG_B_509	100%	74%	0.003	0.957	0.46	0.56	-	-	0	0	100%	0.9333

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.